insights_auto
为什么 DRUG 下跌了 4.91%?
深入探索chevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$71.00
arrow_downward
-4.91%(-3.67) 1 天
10月14日, GMT-4 16:00:00 · CAD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DRUG 生成关键数据洞见…
开盘价
CA$72.00
最高价
CA$75.77
最低价
CA$71.00
市值
7.00亿
平均成交量
848.00
成交量
708.00
52 周最高价
CA$170.00
52 周最低价
CA$68.02
每股收益
-CA$2.90
员工人数
26
开盘价
CA$72.00
最高价
CA$75.77
最低价
CA$71.00
市值
7.00亿
平均成交量
848.00
成交量
708.00
52 周最高价
CA$170.00
52 周最低价
CA$68.02
每股收益
-CA$2.90
员工人数
26
新闻报道
来自网络来源和新闻合作伙伴
资料
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Bright Minds Biosciences Inc简介